6303-99-7

Usage

Uses

Used in Pharmaceutical Industry:
3-(2-aminophenoxy)propanoic acid is used as a building block for the synthesis of pharmaceuticals due to its unique chemical structure and reactivity. Its presence in the molecular composition of various drugs allows for the development of new therapeutic agents with potential applications in treating a range of medical conditions.
Used in Organic Synthesis:
In the field of organic synthesis, 3-(2-aminophenoxy)propanoic acid is utilized as a key intermediate for the production of other organic compounds. Its ability to form various chemical bonds and participate in different reaction pathways makes it a valuable component in the synthesis of specialty chemicals, agrochemicals, and other related products.
Used in Research and Development:
3-(2-aminophenoxy)propanoic acid is employed as a research compound in academic and industrial laboratories. Its unique properties and reactivity make it an interesting subject for studying various chemical reactions and exploring new synthetic routes. Researchers can leverage 3-(2-aminophenoxy)propanoic acid to develop innovative methodologies and improve existing synthetic processes.
It is crucial to handle 3-(2-aminophenoxy)propanoic acid with care and adhere to safety protocols when working with it, given its potential hazardous nature. Proper handling and storage can help minimize risks and ensure the safe use of this valuable chemical compound in various applications.

InChI:InChI=1/C9H11NO3/c10-7-3-1-2-4-8(7)13-6-5-9(11)12/h1-4H,5-6,10H2,(H,11,12)

Upstream product

• 6336-59-0 3-(o-nitrophenoxy)propionic acid 
• 88-75-5 2-hydroxynitrobenzene 

Downstream Products

• 704-48-3 2,3,4,5-tetrahydro-1,5-benzoxazepin-4-one 
• 7160-97-6 2,3,4,5-tetrahydro-1,5-benzoxazepine 

Relevant academic research and scientific papers

3. 4 - diphenyl - 4H - 1, 2, 4 - triazole derivative and its preparation method and application (by machine translation)

The invention discloses 3, 4 - diphenyl - 4H - 1, 2, 4 - triazole derivative and its preparation method and application. In particular, the invention relates to the formula (I) structure of 3, 4 - diphenyl - 4H - 1, 2, 4 - triazole derivatives, its stereoisomers or its pharmaceutically acceptable salt, formula (I) in the definition of each substituent is as defined in the specification. These structure of novel compound with heat shock protein HSP90 inhibitory activity, can be used for treating cancer, neurodegenerative diseases, inflammatory diseases, autoimmune diseases, ischemic brain injury and the like, it has broad application prospects. (by machine translation)

N-CARBAMOYL NITROGEN-CONTAINING FUSED RING COMPOUNDS AND DRUGS CONTAINING THESE COMPOUNDS AS THE ACTIVE INGREDIENT

The present invention relates to the compound presented by formula (I) (wherein all symbols in formula (I) are the same mean as the description shown in the specification.), mitocondorial benzogeazepin receptor (MBR) antagonist comprising the compound, the preventive and/or treatment medicine against diseases caused by stress of which an active ingredient is the compound. Since the compound represented by formula (I) has MBR antagonistic activity, and controls the production of neurosteroid, it is useful as the preventive and/or treatment medicine against diseases caused by stress.

Non-peptidic inhibitors of human neutrophil elastase: The design and synthesis of sulfonanilide-containing inhibitors

A novel series of pivaloyloxy benzene derivatives has been identified as potent and selective human neutrophil elastase (HNE) inhibitors. Convergent syntheses were developed in order to identify the inhibitors which are intravenously effective in an animal model. A compound of particular interest is the sulfonanilide-containing analogues. Structure-activity relationships are discussed. Structural requirements for metabolic stabilization are also discussed.